APRIL ANDREWS: Open Payments
NPI 1326559550 · DUBLIN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 26 payments from 7 companies in 2025. Trend: 2023 $103 · 2024 $550 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $288 |
| Novo Nordisk Inc | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Alkermes, Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $21 |
Products named: AIRSUPRA, BREZTRI, REXULTI, Wegovy, VRAYLAR, Ozempic, VIVITROL, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
